These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 15850403

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Identification of two pairs of spatially approximated residues within the carboxyl terminus of secretin and its receptor.
    Dong M, Asmann YW, Zang M, Pinon DI, Miller LJ.
    J Biol Chem; 2000 Aug 25; 275(34):26032-9. PubMed ID: 10859300
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Identification of ETA and ETB binding domains using ET-derived photoprobes.
    Aubin J, Létourneau M, Francoeur E, Burgeon E, Fournier A.
    Biochimie; 2008 Jun 25; 90(6):918-29. PubMed ID: 18343229
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.
    Clin Cancer Res; 1999 Oct 25; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [Abstract] [Full Text] [Related]

  • 28. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C, Nosal F, Nardeux PC, Gallet X, Guymarho J, Baychelier F, Sempé P, Tovey MG, Escary JL, Eid P.
    Biochemistry; 2004 Oct 05; 43(39):12498-512. PubMed ID: 15449939
    [Abstract] [Full Text] [Related]

  • 29. The efficiency of covalent labeling of the pancreatic cholecystokinin receptor using a battery of crosslinkable and photolabile probes.
    Klueppelberg UG, Powers SP, Miller LJ.
    Receptor; 2004 Oct 05; 1(1-2):1-11. PubMed ID: 2152369
    [Abstract] [Full Text] [Related]

  • 30. Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling.
    Ji Z, Hadac EM, Henne RM, Patel SA, Lybrand TP, Miller LJ.
    J Biol Chem; 1997 Sep 26; 272(39):24393-401. PubMed ID: 9305898
    [Abstract] [Full Text] [Related]

  • 31. Characterization of the new photoaffinity probe (Bz2-K24)-VIP.
    Tan YV, Couvineau A, Lacapere JJ, Laburthe M.
    Ann N Y Acad Sci; 2006 Jul 26; 1070():575-80. PubMed ID: 16888228
    [Abstract] [Full Text] [Related]

  • 32. Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues.
    Kraetke O, Holeran B, Berger H, Escher E, Bienert M, Beyermann M.
    Biochemistry; 2005 Nov 29; 44(47):15569-77. PubMed ID: 16300406
    [Abstract] [Full Text] [Related]

  • 33. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A, Lutz J, Escrieut C, Fourmy D, van Neuren AS, Müller G, Schafferhans A, Klebe G, Moroder L.
    Biopolymers; 2005 Nov 29; 56(2):55-76. PubMed ID: 11592053
    [Abstract] [Full Text] [Related]

  • 34. p-(4-Hydroxybenzoyl)phenylalanine: a photoreactive amino acid analog amenable to radioiodination for elucidation of peptide-protein interaction. Application to substance P receptor.
    Wilson CJ, Husain SS, Stimson ER, Dangott LJ, Miller KW, Maggio JE.
    Biochemistry; 1997 Apr 15; 36(15):4542-51. PubMed ID: 9109663
    [Abstract] [Full Text] [Related]

  • 35. The role of segment 32-47 of cholecystokinin receptor type A in CCK8 binding: synthesis, nuclear magnetic resonance, circular dichroism and fluorescence studies.
    De Luca S, Ragone R, Bracco C, Digilio G, Tesauro D, Saviano M, Pedone C, Morelli G.
    J Pept Sci; 2003 Mar 15; 9(3):156-69. PubMed ID: 12675498
    [Abstract] [Full Text] [Related]

  • 36. Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
    Ceraudo E, Hierso R, Tan YV, Murail S, Rouyer-Fessard C, Nicole P, Robert JC, Jamin N, Neumann JM, Robberecht P, Laburthe M, Couvineau A.
    FASEB J; 2012 May 15; 26(5):2060-71. PubMed ID: 22291440
    [Abstract] [Full Text] [Related]

  • 37. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.
    Boucard AA, Sauvé SS, Guillemette G, Escher E, Leduc R.
    Biochem J; 2003 Mar 15; 370(Pt 3):829-38. PubMed ID: 12495432
    [Abstract] [Full Text] [Related]

  • 38. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
    Gkountelias K, Tselios T, Venihaki M, Deraos G, Lazaridis I, Rassouli O, Gravanis A, Liapakis G.
    Mol Pharmacol; 2009 Apr 15; 75(4):793-800. PubMed ID: 19124613
    [Abstract] [Full Text] [Related]

  • 39. Sequence variation outside the "active" region of dog and rabbit cholecystokinin-58 results in bioactivity differences.
    Reeve JR, Liddle RA, Shively JE, Lee TD, Keire DA, Chew P, Vigna SR.
    Pancreas; 2006 Apr 15; 32(3):306-13. PubMed ID: 16628087
    [Abstract] [Full Text] [Related]

  • 40. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD.
    Protein Sci; 1999 Nov 15; 8(11):2347-54. PubMed ID: 10595537
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.